Although these studies highlight the role of AnxA6 in tumor growth and therapeutic resistance, it remains unclear whether physiological stresses such as hypoxia alter the expression status of AnxA6 in TNBC cells and consequently, metabolic adaptations and the dismal response to targeted therapeutic interventions. The gene discussed is ANXA6; the disease is neoplasm.